Microbiology

  1. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories

    1. P. Simmonds

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Susceptibility of tree shrew to SARS-CoV-2 infection

    1. Yuan Zhao
    2. Junbin Wang
    3. Dexuan Kuang
    4. Jingwen Xu
    5. Mengli Yang
    6. Chunxia Ma
    7. Siwen Zhao
    8. Jingmei Li
    9. Haiting Long
    10. Kaiyun Ding
    11. Jiahong Gao
    12. Jiansheng Liu
    13. Haixuan Wang
    14. Haiyan Li
    15. Yun Yang
    16. Wenhai Yu
    17. Jing Yang
    18. Yinqiu Zheng
    19. Daoju Wu
    20. Shuaiyao Lu
    21. Hongqi Liu
    22. Xiaozhong Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection

    1. Shufeng Liu
    2. Christopher Z. Lien
    3. Prabhuanand Selvaraj
    4. Tony T. Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2

    1. Jason Nomburg
    2. Matthew Meyerson
    3. James A. DeCaprio

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Coronavirus, as a source of pandemic pathogens

    1. T. Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. The coronavirus proofreading exoribonuclease mediates extensive viral recombination

    1. Jennifer Gribble
    2. Laura J. Stevens
    3. Maria L. Agostini
    4. Jordan Anderson-Daniels
    5. James D. Chappell
    6. Xiaotao Lu
    7. Andrea J. Pruijssers
    8. Andrew L. Routh
    9. Mark R. Denison

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases

    1. Kamal Shokeen
    2. Shambhavi Pandey
    3. Manisha Shah
    4. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

    1. Puck B. van Kasteren
    2. Bas van der Veer
    3. Sharon van den Brink
    4. Lisa Wijsman
    5. Jørgen de Jonge
    6. Annemarie van den Brandt
    7. Richard Molenkamp
    8. Chantal B.E.M. Reusken
    9. Adam Meijer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

    1. Farhana Musarrat
    2. Vladimir Chouljenko
    3. Achyut Dahal
    4. Rafiq Nabi
    5. Tamara Chouljenko
    6. Seetharama D. Jois
    7. Konstantin G. Kousoulas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

    1. Cihan TAŞTAN
    2. Bulut YURTSEVER
    3. Gözde SIR KARAKUŞ
    4. Derya DİLEK KANÇAĞI
    5. Sevda DEMİR
    6. Selen ABANUZ
    7. Utku SEYİS
    8. Mülazim YILDIRIM
    9. Recai KUZAY
    10. Ömer ELİBOL
    11. Serap ARBAK
    12. Merve AÇIKEL ELMAS
    13. Selçuk BİRDOĞAN
    14. Osman Uğur SEZERMAN
    15. Ayşe Sesin KOCAGÖZ
    16. Koray YALÇIN
    17. Ercüment OVALI

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 71 of 254 Next